TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
SMP00618	Fosphenytoin (Antiarrhythmic) Metabolism Pathway	0.00139395768382834	-6.57560832303832	4	3	0.0422535211267606	71	978	6640,6331,6641	SNTA1,SCN5A,SNTB1
SMP00499	Beta-mercaptolactate-cysteine disulfiduria	0.00243722424112666	-6.01689549333763	9	4	0.0563380281690141	71	978	2805,2730,2729,1491	GOT1,GCLM,GCLC,CTH
SMP00013	Cysteine Metabolism	0.00243722424112666	-6.01689549333763	9	4	0.0563380281690141	71	978	2805,2730,2729,1491	GOT1,GCLM,GCLC,CTH
SMP00722	Cystinosis- ocular nonnephropathic	0.00243722424112666	-6.01689549333763	9	4	0.0563380281690141	71	978	2730,2805,2729,1491	GCLM,GOT1,GCLC,CTH
SMP00472	Erlotinib Action Pathway	0.0148688491648925	-4.2084869145856	3	2	0.028169014084507	71	978	5243,9429	ABCB1,ABCG2
SMP00650	Doxorubicin Metabolism Pathway	0.0294743872684472	-3.52423362095299	17	4	0.0563380281690141	71	978	1728,7498,5243,9429	NQO1,XDH,ABCB1,ABCG2
SMP00327	Phenytoin (Antiarrhythmic) Action Pathway	0.0444534400175047	-3.11331292929672	77	10	0.140845070422535	71	978	6640,6331,476,1728,801,481,6641,10961,5566,9601	SNTA1,SCN5A,ATP1A1,NQO1,CALM1,ATP1B1,SNTB1,ERP29,PRKACA,PDIA4
SMP00640	Acetaminophen Metabolism Pathway	0.0462008443873319	-3.07475720427939	28	5	0.0704225352112676	71	978	2950,10961,5243,9601,9429	GSTP1,ERP29,ABCB1,PDIA4,ABCG2
SMP00320	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	0.0508531735030759	-2.97881274932823	38	6	0.0845070422535211	71	978	5600,2002,207,9693,6195,4792	MAPK11,ELK1,AKT1,RAPGEF2,RPS6KA1,NFKBIA
SMP00321	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	0.0508531735030759	-2.97881274932823	38	6	0.0845070422535211	71	978	5600,2002,207,9693,6195,4792	MAPK11,ELK1,AKT1,RAPGEF2,RPS6KA1,NFKBIA
SMP00433	Irinotecan Action Pathway	0.0594744828746286	-2.82220791766692	21	4	0.0563380281690141	71	978	10961,5243,9601,9429	ERP29,ABCB1,PDIA4,ABCG2
SMP00600	Irinotecan Metabolism Pathway	0.0594744828746286	-2.82220791766692	21	4	0.0563380281690141	71	978	10961,5243,9601,9429	ERP29,ABCB1,PDIA4,ABCG2
SMP00037	Lysine Degradation	0.0619194754501311	-2.78192052114916	13	3	0.0422535211267606	71	978	55526,6542,10157	DHTKD1,SLC7A2,AASS
SMP00186	Glutaric Aciduria Type I	0.0619194754501311	-2.78192052114916	13	3	0.0422535211267606	71	978	55526,6542,10157	DHTKD1,SLC7A2,AASS
SMP00528	Hyperlysinemia II or Saccharopinuria	0.0619194754501311	-2.78192052114916	13	3	0.0422535211267606	71	978	55526,6542,10157	DHTKD1,SLC7A2,AASS
SMP00527	Hyperlysinemia I- Familial	0.0619194754501311	-2.78192052114916	13	3	0.0422535211267606	71	978	55526,6542,10157	DHTKD1,SLC7A2,AASS
SMP00043	Galactose Metabolism	0.0619194754501311	-2.78192052114916	13	3	0.0422535211267606	71	978	5236,2548,2717	PGM1,GAA,GLA
SMP00239	Saccharopinuria/Hyperlysinemia II	0.0619194754501311	-2.78192052114916	13	3	0.0422535211267606	71	978	55526,6542,10157	DHTKD1,SLC7A2,AASS
SMP00719	2-aminoadipic 2-oxoadipic aciduria	0.0619194754501311	-2.78192052114916	13	3	0.0422535211267606	71	978	55526,6542,10157	DHTKD1,SLC7A2,AASS
SMP00571	Pyridoxine dependency with seizures	0.0619194754501311	-2.78192052114916	13	3	0.0422535211267606	71	978	55526,6542,10157	DHTKD1,SLC7A2,AASS
SMP00182	Galactosemia	0.0619194754501311	-2.78192052114916	13	3	0.0422535211267606	71	978	5236,2548,2717	PGM1,GAA,GLA
SMP00136	2-Hydroxyglutric Aciduria (D And L Form)	0.068820900461664	-2.6762477943964	22	4	0.0563380281690141	71	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00567	Succinic semialdehyde dehydrogenase deficiency	0.068820900461664	-2.6762477943964	22	4	0.0563380281690141	71	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00339	Hyperinsulinism-Hyperammonemia Syndrome	0.068820900461664	-2.6762477943964	22	4	0.0563380281690141	71	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00243	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	0.068820900461664	-2.6762477943964	22	4	0.0563380281690141	71	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00385	Homocarnosinosis	0.068820900461664	-2.6762477943964	22	4	0.0563380281690141	71	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00072	Glutamate Metabolism	0.068820900461664	-2.6762477943964	22	4	0.0563380281690141	71	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00044	Histidine Metabolism	0.0748137142783202	-2.59275406484068	14	3	0.0422535211267606	71	978	217,144193,3034	ALDH2,AMDHD1,HAL
SMP00191	Histidinemia	0.0748137142783202	-2.59275406484068	14	3	0.0422535211267606	71	978	217,144193,3034	ALDH2,AMDHD1,HAL
SMP00434	Paclitaxel Action Pathway	0.0860382096364396	-2.45296378330167	7	2	0.028169014084507	71	978	5243,9429	ABCB1,ABCG2
SMP00682	Leucine Stimulation on Insulin Signaling	0.0860382096364396	-2.45296378330167	7	2	0.028169014084507	71	978	207,6009	AKT1,RHEB
SMP00041	Sulfate/Sulfite Metabolism	0.0860382096364396	-2.45296378330167	7	2	0.028169014084507	71	978	9060,6820	PAPSS2,SULT2B1
SMP00435	Docetaxel Action Pathway	0.0860382096364396	-2.45296378330167	7	2	0.028169014084507	71	978	5243,9429	ABCB1,ABCG2
SMP00532	Sulfite oxidase deficiency	0.0860382096364396	-2.45296378330167	7	2	0.028169014084507	71	978	9060,6820	PAPSS2,SULT2B1
SMP00306	Pindolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00323	Quinidine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00660	Sotalol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00379	Nifedipine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00325	Disopyramide Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00669	Practolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00667	Metipranolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00380	Nimodipine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00381	Nisoldipine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00659	Timolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00661	Epinephrine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00324	Procainamide (Antiarrhythmic) Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00366	Nebivolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00377	Felodipine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00296	Acebutolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00305	Penbutolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00663	Isoprenaline Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00658	Carteolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00657	Bopindolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00664	Arbutamine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00588	Muscle/Heart Contraction	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00298	Atenolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00304	Oxprenolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00332	Ibutilide Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00665	Amiodarone Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00378	Isradipine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00670	Bupranolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00303	Nadolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00297	Alprenolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00331	Flecainide Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00359	Diltiazem Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00375	Verapamil Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00382	Nitrendipine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00662	Dobutamine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00329	Mexiletine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00302	Metoprolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00300	Bisoprolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00376	Amlodipine Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00301	Esmolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00299	Betaxolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00330	Tocainide Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00307	Propranolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00326	Fosphenytoin (Antiarrhythmic) Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00666	Levobunolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00668	Bevantolol Action Pathway	0.111195704513189	-2.19646352639027	57	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00368	Labetalol Action Pathway	0.119343368079181	-2.12575049473591	58	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00367	Carvedilol Action Pathway	0.119343368079181	-2.12575049473591	58	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00328	Lidocaine (Antiarrhythmic) Action Pathway	0.127798953378557	-2.05729692659839	59	7	0.0985915492957746	71	978	6640,6331,476,481,6641,5566,801	SNTA1,SCN5A,ATP1A1,ATP1B1,SNTB1,PRKACA,CALM1
SMP00351	GABA-Transaminase Deficiency	0.134327662205815	-2.00747322342488	9	2	0.028169014084507	71	978	217,2571	ALDH2,GAD1
SMP00492	Ureidopropionase deficiency	0.134327662205815	-2.00747322342488	9	2	0.028169014084507	71	978	217,2571	ALDH2,GAD1
SMP00493	Carnosinuria- carnosinemia	0.134327662205815	-2.00747322342488	9	2	0.028169014084507	71	978	217,2571	ALDH2,GAD1
SMP00007	Beta-Alanine Metabolism	0.134327662205815	-2.00747322342488	9	2	0.028169014084507	71	978	217,2571	ALDH2,GAD1
SMP00442	Etoposide Action Pathway	0.13648558959562	-1.99153624065816	18	3	0.0422535211267606	71	978	10961,5243,9601	ERP29,ABCB1,PDIA4
SMP00649	Lamivudine Metabolism Pathway	0.13648558959562	-1.99153624065816	18	3	0.0422535211267606	71	978	1633,5243,9429	DCK,ABCB1,ABCG2
SMP00601	Etoposide Metabolism Pathway	0.13648558959562	-1.99153624065816	18	3	0.0422535211267606	71	978	10961,5243,9601	ERP29,ABCB1,PDIA4
SMP00455	Homocysteine Degradation	0.139992841487019	-1.96616398991571	2	1	0.0140845070422535	71	978	1491	CTH
SMP00515	Homocystinuria- cystathionine beta-synthase deficiency	0.139992841487019	-1.96616398991571	2	1	0.0140845070422535	71	978	1491	CTH
SMP00514	Gamma-cystathionase deficiency (CTH)	0.139992841487019	-1.96616398991571	2	1	0.0140845070422535	71	978	1491	CTH
SMP00406	Morphine Action Pathway	0.157911066999313	-1.84572327151728	40	5	0.0704225352112676	71	978	476,481,10961,2902,9601	ATP1A1,ATP1B1,ERP29,GRIN1,PDIA4
SMP00437	Vincristine Action Pathway	0.16030964708611	-1.83064803972948	10	2	0.028169014084507	71	978	5243,7157	ABCB1,TP53
SMP00438	Vindesine Action Pathway	0.16030964708611	-1.83064803972948	10	2	0.028169014084507	71	978	5243,7157	ABCB1,TP53
SMP00363	Ornithine Aminotransferase Deficiency (OAT Deficiency)	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00506	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00507	L-arginine:glycine amidinotransferase deficiency	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00505	Hyperornithinemia with gyrate atrophy (HOGA)	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00362	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00504	Creatine deficiency- guanidinoacetate methyltransferase deficiency	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00207	Prolidase Deficiency (PD)	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00360	Hyperprolinemia Type II	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00188	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00208	Prolinemia Type II	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00361	Hyperprolinemia Type I	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00020	Arginine and Proline Metabolism	0.172220553850948	-1.75897933376906	20	3	0.0422535211267606	71	978	5625,2805,4942	PRODH,GOT1,OAT
SMP00436	Vinblastine Action Pathway	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	5243,7157	ABCB1,TP53
SMP00015	Glutathione Metabolism	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	2730,2729	GCLM,GCLC
SMP00500	5-oxoprolinase deficiency	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	2730,2729	GCLM,GCLC
SMP00370	Tyrosinemia Type 3 (TYRO3)	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00008	Phenylalanine and Tyrosine Metabolism	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00439	Vinorelbine Action Pathway	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	5243,7157	ABCB1,TP53
SMP00337	Glutathione Synthetase Deficiency	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	2730,2729	GCLM,GCLC
SMP00143	5-Oxoprolinuria	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	2730,2729	GCLM,GCLC
SMP00501	Gamma-glutamyl-transpeptidase deficiency	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	2730,2729	GCLM,GCLC
SMP00029	Selenoamino Acid Metabolism	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	9061,1491	PAPSS1,CTH
SMP00206	Phenylketonuria	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00183	Gamma-Glutamyltransferase Deficiency	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	2730,2729	GCLM,GCLC
SMP00369	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	0.187120717342304	-1.67600132311852	11	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00525	Fabry disease	0.191011565680428	-1.65542129946812	21	3	0.0422535211267606	71	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00526	Krabbe disease	0.191011565680428	-1.65542129946812	21	3	0.0422535211267606	71	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00349	Gaucher Disease	0.191011565680428	-1.65542129946812	21	3	0.0422535211267606	71	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00034	Sphingolipid Metabolism	0.191011565680428	-1.65542129946812	21	3	0.0422535211267606	71	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00347	Metachromatic Leukodystrophy (MLD)	0.191011565680428	-1.65542129946812	21	3	0.0422535211267606	71	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00348	Globoid Cell Leukodystrophy	0.191011565680428	-1.65542129946812	21	3	0.0422535211267606	71	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00464	Vitamin K Metabolism	0.202554837651148	-1.59674462588057	3	1	0.0140845070422535	71	978	1728	NQO1
SMP00458	Lactose Intolerance	0.214508489006221	-1.53940596561059	12	2	0.028169014084507	71	978	481,476	ATP1B1,ATP1A1
SMP00457	Lactose Degradation	0.214508489006221	-1.53940596561059	12	2	0.028169014084507	71	978	476,481	ATP1A1,ATP1B1
SMP00078	Chlorothiazide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00088	Bumetanide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00115	Furosemide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00105	Metolazone Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00197	Lysinuric Protein Intolerance	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00245	Glucose Transporter Defect (SGLT2)	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00090	Bendroflumethiazide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00100	Hydrochlorothiazide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00583	Blue diaper syndrome	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00135	Eplerenone Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00483	Kidney Function	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00081	Methyclothiazide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00108	Hydroflumethiazide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00723	Cystinuria	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00134	Spironolactone Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00118	Torsemide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00189	Hartnup Disorder	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00133	Amiloride Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00184	Glucose Transporter Defect (SGLT2)	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00097	Ethacrynic Acid Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00091	Quinethazone Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00585	Lysinuric protein intolerance (LPI)	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00132	Triamterene Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00103	Cyclothiazide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00110	Indapamide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00193	Iminoglycinuria	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00121	Trichlormethiazide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00080	Polythiazide Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00122	Chlorthalidone Action Pathway	0.22884673194306	-1.47470279232939	34	4	0.0563380281690141	71	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00467	Trehalose Degradation	0.242251946017152	-1.41777699514899	13	2	0.028169014084507	71	978	476,481	ATP1A1,ATP1B1
SMP00554	Glycogenosis- Type IV. Amylopectinosis	0.242251946017152	-1.41777699514899	13	2	0.028169014084507	71	978	283209,5236	PGM2L1,PGM1
SMP00553	Glycogenosis- Type III. Cori disease	0.242251946017152	-1.41777699514899	13	2	0.028169014084507	71	978	283209,5236	PGM2L1,PGM1
SMP00429	Disulfiram Action Pathway	0.250070994133082	-1.38601042490127	24	3	0.0422535211267606	71	978	2805,217,2184	GOT1,ALDH2,FAH
SMP00086	Ibuprofen Action Pathway	0.25057416431618	-1.3840003371414	47	5	0.0704225352112676	71	978	113612,4048,10961,4051,9601	CYP2U1,LTA4H,ERP29,CYP4F3,PDIA4
SMP00450	Phytanic Acid Peroxisomal Oxidation	0.260625203320045	-1.3446719063045	4	1	0.0140845070422535	71	978	224	ALDH3A2
SMP00451	Refsum Disease	0.260625203320045	-1.3446719063045	4	1	0.0140845070422535	71	978	224	ALDH3A2
SMP00648	Sorafenib Metabolism Pathway	0.270158317973444	-1.30874712896269	14	2	0.028169014084507	71	978	10961,9601	ERP29,PDIA4
SMP00462	Inositol Phosphate Metabolism	0.270158317973444	-1.30874712896269	14	2	0.028169014084507	71	978	51477,3706	ISYNA1,ITPKA
SMP00004	Glycine and Serine Metabolism	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	217,1491,63826	ALDH2,CTH,SRR
SMP00674	Anileridine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00411	Hydrocodone Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00689	Dihydromorphine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00687	Naltrexone Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00675	Diphenoxylate Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00484	Dimethylglycine Dehydrogenase Deficiency	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	217,1491,63826	ALDH2,CTH,SRR
SMP00417	Sufentanil Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00686	Pentazocine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00404	Ropivacaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00244	Sarcosinemia	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	217,1491,63826	ALDH2,CTH,SRR
SMP00425	Escitalopram Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00679	3-Methylthiofentanyl Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00681	Ethylmorphine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00684	Buprenorphine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00672	Propoxyphene Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00690	Ketobemidone  Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00392	Benzocaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00410	Hydromorphone Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00399	Mepivacaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00678	Methadyl Acetate Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00416	Remifentanil Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00242	Dimethylglycine Dehydrogenase Deficiency	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	217,1491,63826	ALDH2,CTH,SRR
SMP00223	Non Ketotic Hyperglycinemia	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	217,1491,63826	ALDH2,CTH,SRR
SMP00179	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	217,1491,63826	ALDH2,CTH,SRR
SMP00671	Tramadol Action Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00393	Bupivacaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00721	3-Phosphoglycerate dehydrogenase deficiency	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	217,1491,63826	ALDH2,CTH,SRR
SMP00396	Dibucaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00415	Fentanyl Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00673	Levorphanol Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00401	Prilocaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00685	Alvimopan Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00400	Oxybuprocaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00394	Chloroprocaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00414	Carfentanil Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00397	Levobupivacaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00676	Dezocine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00413	Alfentanil Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00395	Cocaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00412	Oxymorphone Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00688	Naloxone Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00403	Proparacaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00677	Levomethadyl Acetate Action Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00683	Levallorphan Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00402	Procaine Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00680	Dimethylthiambutene Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00485	Hyperglycinemia- non-ketotic	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	217,1491,63826	ALDH2,CTH,SRR
SMP00409	Oxycodone Action Pathway	0.290895614653229	-1.23479078869523	26	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00622	Morphine Metabolism Pathway	0.298060236311845	-1.21045967762867	15	2	0.028169014084507	71	978	10961,9601	ERP29,PDIA4
SMP00494	Tyrosinemia- transient	0.298060236311845	-1.21045967762867	15	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00691	Nalbuphine Action Pathway	0.311525466295317	-1.16627419033925	27	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00423	Desipramine Action Pathway	0.311525466295317	-1.16627419033925	27	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00021	Taurine and Hypotaurine Metabolism	0.314522134084896	-1.15670082666978	5	1	0.0140845070422535	71	978	2571	GAD1
SMP00469	Capecitabine Action Pathway	0.314522134084896	-1.15670082666978	5	1	0.0140845070422535	71	978	978	CDA
SMP00607	Capecitabine Metabolism Pathway	0.314522134084896	-1.15670082666978	5	1	0.0140845070422535	71	978	978	CDA
SMP00555	Glycogenosis- Type VI. Hers disease	0.325813145741157	-1.12143123451476	16	2	0.028169014084507	71	978	283209,5236	PGM2L1,PGM1
SMP00652	Mycophenolic Acid Metabolism Pathway	0.325813145741157	-1.12143123451476	16	2	0.028169014084507	71	978	5243,9429	ABCB1,ABCG2
SMP00058	Starch and Sucrose Metabolism	0.325813145741157	-1.12143123451476	16	2	0.028169014084507	71	978	283209,5236	PGM2L1,PGM1
SMP00557	Sucrase-isomaltase deficiency	0.325813145741157	-1.12143123451476	16	2	0.028169014084507	71	978	283209,5236	PGM2L1,PGM1
SMP00556	Mucopolysaccharidosis VI. Sly syndrome	0.325813145741157	-1.12143123451476	16	2	0.028169014084507	71	978	283209,5236	PGM2L1,PGM1
SMP00552	Glycogen synthetase deficiency	0.325813145741157	-1.12143123451476	16	2	0.028169014084507	71	978	283209,5236	PGM2L1,PGM1
SMP00706	Tenoxicam Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00693	Antrafenine Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00102	Bromfenac Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00699	Lumiracoxib Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00098	Ketorolac Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00106	Meloxicam Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00707	Salsalate Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00085	Ketoprofen Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00692	Antipyrine Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00353	Leukotriene C4 Synthesis Deficiency	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00700	Lornoxicam Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00701	Phenylbutazone Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00398	Lidocaine (Local Anaesthetic) Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00094	Sulindac Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00114	Nabumetone Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00109	Mefenamic Acid Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00113	Oxaprozin Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00702	Nepafenac Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00698	Magnesium salicylate Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00289	Diflunisal Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00708	Salicylate-sodium Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00077	Piroxicam Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00083	Acetylsalicylic Acid Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00710	Acetaminophen  Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00697	Flurbiprofen Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00084	Etodolac Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00075	Arachidonic Acid Metabolism	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00696	Fenoprofen Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00703	Trisalicylate-choline Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00709	Salicylic Acid Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00093	Diclofenac Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00695	Etoricoxib Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00101	Suprofen Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00704	Tolmetin Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00694	Carprofen Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00705	Tiaprofenic Acid Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00087	Rofecoxib Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00116	Valdecoxib Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00120	Naproxen Action Pathway	0.332212586926533	-1.10198019291648	28	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00405	Codeine Action Pathway	0.352896357416361	-1.04158087021204	29	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00104	Indomethacin Action Pathway	0.352896357416361	-1.04158087021204	29	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00407	Heroin Action Pathway	0.352896357416361	-1.04158087021204	29	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00218	Tyrosinemia Type I	0.353292949615747	-1.04045768061648	17	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00498	Dopamine beta-hydroxylase deficiency	0.353292949615747	-1.04045768061648	17	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00533	Monoamine oxidase-a deficiency (MAO-A)	0.353292949615747	-1.04045768061648	17	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00190	Hawkinsinuria	0.353292949615747	-1.04045768061648	17	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00006	Tyrosine Metabolism	0.353292949615747	-1.04045768061648	17	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00169	Alkaptonuria	0.353292949615747	-1.04045768061648	17	2	0.028169014084507	71	978	2805,2184	GOT1,FAH
SMP00636	Venlafaxine Metabolism Pathway	0.364541587816395	-1.00911463852359	6	1	0.0140845070422535	71	978	5243	ABCB1
SMP00422	Imipramine Action Pathway	0.373520392551016	-0.984782677369548	30	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00426	Fluoxetine Action Pathway	0.394032543226449	-0.931321776073706	31	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00063	Tryptophan Metabolism	0.407026501665415	-0.898876981002369	19	2	0.028169014084507	71	978	217,1543	ALDH2,CYP1A1
SMP00449	Ethanol Degradation	0.410958817513436	-0.889262270203564	7	1	0.0140845070422535	71	978	217	ALDH2
SMP00424	Citalopram Action Pathway	0.414384857022875	-0.880960130637753	32	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00358	Fc Epsilon Receptor I Signaling in Mast Cells	0.414384857022875	-0.880960130637753	32	3	0.0422535211267606	71	978	207,6850,5295	AKT1,SYK,PIK3R1
SMP00431	Nicotine Action Pathway	0.414384857022875	-0.880960130637753	32	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00408	Methadone Action Pathway	0.414384857022875	-0.880960130637753	32	3	0.0422535211267606	71	978	476,481,2902	ATP1A1,ATP1B1,GRIN1
SMP00487	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	6697	SPR
SMP00496	Galactosemia III	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	5236	PGM1
SMP00030	Oxidation of Branched Chain Fatty Acids	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	217	ALDH2
SMP00005	Pterine Biosynthesis	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	6697	SPR
SMP00488	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	6697	SPR
SMP00495	Galactosemia II (GALK)	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	5236	PGM1
SMP00010	Nucleotide Sugars Metabolism	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	5236	PGM1
SMP00028	Caffeine Metabolism	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	7498	XDH
SMP00490	Segawa syndrome	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	6697	SPR
SMP00491	Sepiapterin reductase deficiency	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	6697	SPR
SMP00486	Dopa-responsive dystonia	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	6697	SPR
SMP00489	Hyperphenylalaninemia due to dhpr-deficiency	0.454029799961419	-0.789592444413373	8	1	0.0140845070422535	71	978	6697	SPR
SMP00096	Celecoxib Action Pathway	0.454438675767907	-0.788692301271328	34	3	0.0422535211267606	71	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00011	Inositol Metabolism	0.458600734132875	-0.779575307746541	21	2	0.028169014084507	71	978	51477,3706	ISYNA1,ITPKA
SMP00582	Joubert syndrome	0.458600734132875	-0.779575307746541	21	2	0.028169014084507	71	978	5293,5295	PIK3CD,PIK3R1
SMP00463	Phosphatidylinositol Phosphate Metabolism	0.458600734132875	-0.779575307746541	21	2	0.028169014084507	71	978	5293,5295	PIK3CD,PIK3R1
SMP00590	Ibuprofen Metabolism Pathway	0.483430324684972	-0.7268480806055	22	2	0.028169014084507	71	978	10961,9601	ERP29,PDIA4
SMP00610	Clopidogrel Metabolism Pathway	0.493992567181799	-0.7052348080981	9	1	0.0140845070422535	71	978	5243	ABCB1
SMP00716	Thyroid hormone synthesis	0.493992567181799	-0.7052348080981	9	1	0.0140845070422535	71	978	53905	DUOX1
SMP00260	Clopidogrel Action Pathway	0.493992567181799	-0.7052348080981	9	1	0.0140845070422535	71	978	5243	ABCB1
SMP00219	UMP Synthase Deiciency (Orotic Aciduria)	0.50756484501004	-0.678130802809725	23	2	0.028169014084507	71	978	129607,978	CMPK2,CDA
SMP00202	MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	0.50756484501004	-0.678130802809725	23	2	0.028169014084507	71	978	129607,978	CMPK2,CDA
SMP00172	Beta Ureidopropionase Deficiency	0.50756484501004	-0.678130802809725	23	2	0.028169014084507	71	978	129607,978	CMPK2,CDA
SMP00046	Pyrimidine Metabolism	0.50756484501004	-0.678130802809725	23	2	0.028169014084507	71	978	129607,978	CMPK2,CDA
SMP00178	Dihydropyrimidinase Deficiency	0.50756484501004	-0.678130802809725	23	2	0.028169014084507	71	978	129607,978	CMPK2,CDA
SMP00624	Methadone Metabolism Pathway	0.531068447193247	-0.63286436361191	10	1	0.0140845070422535	71	978	2902	GRIN1
SMP00391	Insulin Signalling	0.565463220178696	-0.570110025012921	11	1	0.0140845070422535	71	978	207	AKT1
SMP00009	Ammonia Recycling	0.565463220178696	-0.570110025012921	11	1	0.0140845070422535	71	978	3034	HAL
SMP00543	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.597368195740719	-0.515221612413227	12	1	0.0140845070422535	71	978	8836	GGH
SMP00053	Folate Metabolism	0.597368195740719	-0.515221612413227	12	1	0.0140845070422535	71	978	8836	GGH
SMP00432	Methotrexate Action Pathway	0.597368195740719	-0.515221612413227	12	1	0.0140845070422535	71	978	8836	GGH
SMP00068	Androgen and Estrogen Metabolism	0.597368195740719	-0.515221612413227	12	1	0.0140845070422535	71	978	6820	SULT2B1
SMP00565	Aromatase deficiency	0.597368195740719	-0.515221612413227	12	1	0.0140845070422535	71	978	6820	SULT2B1
SMP00724	Folate malabsorption- hereditary	0.597368195740719	-0.515221612413227	12	1	0.0140845070422535	71	978	8836	GGH
SMP00356	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	0.597368195740719	-0.515221612413227	12	1	0.0140845070422535	71	978	6820	SULT2B1
SMP00603	Gemcitabine Metabolism Pathway	0.626961216552681	-0.466870595840213	13	1	0.0140845070422535	71	978	1633	DCK
SMP00446	Gemcitabine Action Pathway	0.626961216552681	-0.466870595840213	13	1	0.0140845070422535	71	978	1633	DCK
SMP00282	Streptokinase Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00268	Warfarin Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00276	Argatroban Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00288	Aprotinin Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00279	Ximelagatran Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00281	Anistreplase Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00656	Dicoumarol Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00048	Nicotinate and Nicotinamide Metabolism	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	54981	NMRK1
SMP00283	Tenecteplase Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00269	Acenocoumarol Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00280	Alteplase Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00277	Bivalirudin Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00271	Phenprocoumon Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00285	Reteplase Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00278	Lepirudin Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00655	Phenindione Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00586	Coagulation 	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00284	Urokinase Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00287	Tranexamic Acid Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00067	Aspartate Metabolism	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2571	GAD1
SMP00270	Dicumarol Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00175	Canavan Disease	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2571	GAD1
SMP00192	Hypoacetylaspartia	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2571	GAD1
SMP00286	Aminocaproic Acid Action Pathway	0.65440759336635	-0.424024890205985	14	1	0.0140845070422535	71	978	2161	F12
SMP00522	3-hydroxyisobutyric aciduria	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00524	Isovaleric acidemia	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00523	Isobutyryl-coa dehydrogenase deficiency	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00237	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00238	Isovaleric Aciduria	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00199	Maple Syrup Urine Disease	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00521	3-hydroxyisobutyric acid dehydrogenase deficiency	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00236	Propionic Acidemia	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00200	Methylmalonic Aciduria	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00384	Methylmalonate Semialdehyde Dehydrogenase Deficiency	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00140	3-Methylglutaconic Aciduria Type III	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00139	3-Methylglutaconic Aciduria Type I	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00032	Valine- Leucine and Isoleucine Degradation	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00173	Beta-Ketothiolase Deficiency	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00141	3-Methylglutaconic Aciduria Type IV	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00137	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00138	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	0.655339506185405	-0.422601847579452	30	2	0.028169014084507	71	978	217,64087	ALDH2,MCCC2
SMP00275	Ardeparin Action Pathway	0.679860976014379	-0.385866948751807	15	1	0.0140845070422535	71	978	2161	F12
SMP00518	Glucose-6-phosphate dehydrogenase deficiency	0.679860976014379	-0.385866948751807	15	1	0.0140845070422535	71	978	5236	PGM1
SMP00609	Mercaptopurine Metabolism Pathway	0.679860976014379	-0.385866948751807	15	1	0.0140845070422535	71	978	7498	XDH
SMP00031	Pentose Phosphate Pathway	0.679860976014379	-0.385866948751807	15	1	0.0140845070422535	71	978	5236	PGM1
SMP00273	Fondaparinux Action Pathway	0.679860976014379	-0.385866948751807	15	1	0.0140845070422535	71	978	2161	F12
SMP00274	Heparin Action Pathway	0.679860976014379	-0.385866948751807	15	1	0.0140845070422535	71	978	2161	F12
SMP00272	Enoxaparin Action Pathway	0.679860976014379	-0.385866948751807	15	1	0.0140845070422535	71	978	2161	F12
SMP00519	Ribose-5-phosphate isomerase deficiency	0.679860976014379	-0.385866948751807	15	1	0.0140845070422535	71	978	5236	PGM1
SMP00520	Transaldolase deficiency	0.679860976014379	-0.385866948751807	15	1	0.0140845070422535	71	978	5236	PGM1
SMP00317	Familial Hypercholanemia (FHCA)	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	8309	ACOX2
SMP00316	Zellweger Syndrome	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	8309	ACOX2
SMP00315	Cerebrotendinous Xanthomatosis (CTX)	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	8309	ACOX2
SMP00314	Congenital Bile Acid Synthesis Defect Type II	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	8309	ACOX2
SMP00035	Bile Acid Biosynthesis	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	8309	ACOX2
SMP00390	Tay-Sachs Disease	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	2673	GFPT1
SMP00045	Amino Sugar Metabolism	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	2673	GFPT1
SMP00240	Salla Disease/Infantile Sialic Acid Storage Disease	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	2673	GFPT1
SMP00534	G(M2)-Gangliosidosis: Variant B- Tay-sachs disease	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	2673	GFPT1
SMP00216	Sialuria or French Type Sialuria	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	2673	GFPT1
SMP00217	Sialuria or French Type Sialuria	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	2673	GFPT1
SMP00318	Congenital Bile Acid Synthesis Defect Type III	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	8309	ACOX2
SMP00720	27-Hydroxylase Deficiency	0.725349865643648	-0.321101167226928	17	1	0.0140845070422535	71	978	8309	ACOX2
SMP00336	Vitamin A Deficiency	0.738025625958729	-0.3037767314632	35	2	0.028169014084507	71	978	10961,9601	ERP29,PDIA4
SMP00074	Retinol Metabolism	0.738025625958729	-0.3037767314632	35	2	0.028169014084507	71	978	10961,9601	ERP29,PDIA4
SMP00340	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.764453333331667	-0.268594297553773	19	1	0.0140845070422535	71	978	1491	CTH
SMP00214	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	0.764453333331667	-0.268594297553773	19	1	0.0140845070422535	71	978	1491	CTH
SMP00221	Methionine Adenosyltransferase Deficiency	0.764453333331667	-0.268594297553773	19	1	0.0140845070422535	71	978	1491	CTH
SMP00177	Cystathionine Beta-Synthase Deficiency	0.764453333331667	-0.268594297553773	19	1	0.0140845070422535	71	978	1491	CTH
SMP00341	Hypermethioninemia	0.764453333331667	-0.268594297553773	19	1	0.0140845070422535	71	978	1491	CTH
SMP00033	Methionine Metabolism	0.764453333331667	-0.268594297553773	19	1	0.0140845070422535	71	978	1491	CTH
SMP00222	Glycine N-methyltransferase Deficiency	0.764453333331667	-0.268594297553773	19	1	0.0140845070422535	71	978	1491	CTH
SMP00570	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism- cblG complementation type	0.764453333331667	-0.268594297553773	19	1	0.0140845070422535	71	978	1491	CTH
SMP00128	Gluconeogenesis	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	5236	PGM1
SMP00060	Pyruvate Metabolism	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	217	ALDH2
SMP00581	Glycogenosis- Type IA. Von gierke disease	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	5236	PGM1
SMP00574	Glycogenosis- Type IC	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	5236	PGM1
SMP00334	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	217	ALDH2
SMP00563	Triosephosphate isomerase	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	5236	PGM1
SMP00562	Fructose-1-6-diphosphatase deficiency	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	5236	PGM1
SMP00196	Leigh Syndrome	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	217	ALDH2
SMP00212	Pyruvate Dehydrogenase Complex Deficiency	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	217	ALDH2
SMP00374	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	5236	PGM1
SMP00558	Primary hyperoxaluria II- PH2	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	217	ALDH2
SMP00560	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	5236	PGM1
SMP00573	Glycogenosis- Type IB	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	5236	PGM1
SMP00559	Pyruvate kinase deficiency	0.813038916540952	-0.206976302755906	22	1	0.0140845070422535	71	978	217	ALDH2
SMP00203	Molybdenum Cofactor Deficiency	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00167	Adenylosuccinate Lyase Deficiency	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00365	Gout or Kelley-Seegmiller Syndrome	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00220	Xanthine Dehydrogenase Deficiency (Xanthinuria)	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00537	Myoadenylate deaminase deficiency	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00050	Purine Metabolism	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00144	Adenosine Deaminase Deficiency	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00536	Mitochondrial DNA depletion syndrome	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00535	Adenine phosphoribosyltransferase deficiency (APRT)	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00512	Xanthinuria type I	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00513	Xanthinuria type II	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00210	Purine Nucleoside Phosphorylase Deficiency	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00364	Lesch-Nyhan Syndrome (LNS)	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00168	AICA-Ribosiduria	0.941767637820377	-0.0599967038140625	37	1	0.0140845070422535	71	978	7498	XDH
SMP00654	Warburg Effect	0.9689872011512	-0.0315038754848963	45	1	0.0140845070422535	71	978	3417	IDH1
SMP00428	Mercaptopurine Action Pathway	0.973530007186051	-0.0268266306222814	47	1	0.0140845070422535	71	978	7498	XDH
SMP00430	Thioguanine Action Pathway	0.973530007186051	-0.0268266306222814	47	1	0.0140845070422535	71	978	7498	XDH
SMP00427	Azathioprine Action Pathway	0.973530007186051	-0.0268266306222814	47	1	0.0140845070422535	71	978	7498	XDH
SMP00612	Esomeprazole Metabolism Pathway	0.999999999998159	-1.84085212351359e-12	2	0	0	71	978
SMP00616	Rabeprazole Metabolism Pathway	0.999999999998159	-1.84085212351359e-12	2	0	0	71	978
SMP00613	Omeprazole Metabolism Pathway	0.999999999998159	-1.84085212351359e-12	2	0	0	71	978
SMP00614	Lansoprazole Metabolism Pathway	0.999999999998159	-1.84085212351359e-12	2	0	0	71	978
SMP00615	Pantoprazole Metabolism Pathway	0.999999999998159	-1.84085212351359e-12	2	0	0	71	978
SMP00456	Fatty Acid Biosynthesis	0.999999999998159	-1.84085212351359e-12	2	0	0	71	978
SMP00420	Bevacizumab Action Pathway	0.999999999999842	-1.57586183685554e-13	3	0	0	71	978
SMP00653	Rosiglitazone Metabolism Pathway	0.999999999999842	-1.57586183685554e-13	3	0	0	71	978
SMP00126	Phenylacetate Metabolism	0.999999999999842	-1.57586183685554e-13	3	0	0	71	978
SMP00564	Multiple carboxylase deficiency- neonatal or early onset form	0.999999999999842	-1.57586183685554e-13	3	0	0	71	978
SMP00619	Felodipine Metabolism Pathway	0.999999999999842	-1.57586183685554e-13	3	0	0	71	978
SMP00626	Desipramine Metabolism Pathway	0.999999999999842	-1.57586183685554e-13	3	0	0	71	978
SMP00124	Glycerol Phosphate Shuttle	0.999999999999842	-1.57586183685554e-13	3	0	0	71	978
SMP00459	Pyruvaldehyde Degradation	0.999999999999842	-1.57586183685554e-13	3	0	0	71	978
SMP00174	Biotinidase Deficiency	0.999999999999842	-1.57586183685554e-13	3	0	0	71	978
SMP00066	Biotin Metabolism	0.999999999999842	-1.57586183685554e-13	3	0	0	71	978
SMP00631	Prednisone Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00265	Abciximab Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00476	Trastuzumab Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00593	Enalapril Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00732	Temocapril Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00632	Prednisolone Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00473	Gefitinib Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00261	Ticlopidine Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00595	Moexipril Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00475	Panitumumab Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00647	Thioguanine Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00474	Cetuximab Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00591	Benazepril Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00597	Ramipril Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00267	Tirofiban Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00596	Quinapril Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00617	Cimetidine Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00421	Vatalanib Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00592	Cilazapril Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00036	D-Arginine and D-Ornithine Metabolism	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00470	Fluorouracil Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00611	Ticlopidine Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00599	Trandolapril Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00263	Cilostazol Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00594	Fosinopril Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00598	Spirapril Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00264	Dipyridamole (Antiplatelet) Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00440	Prednisone Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00638	Levomethadyl Acetate Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00441	Prednisolone Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00266	Eptifibatide Action Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00608	Fluorouracil Metabolism Pathway	0.999999999999969	-3.06699110552699e-14	1	0	0	71	978
SMP00153	Quinapril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00623	Heroin Metabolism Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00165	Valsartan Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00602	Teniposide Metabolism Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00150	Lisinopril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00633	Felbamate Metabolism Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00164	Telmisartan Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00076	Thiamine Metabolism	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00651	Artemether Metabolism Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00170	Aromatic L-Aminoacid Decarboxylase Deficiency	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00145	Benazepril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00620	Lidocaine (Local Anaesthetic) Metabolism Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00443	Teniposide Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00733	Temocapril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00621	Codeine Metabolism Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00152	Perindopril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00012	Catecholamine Biosynthesis	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00149	Fosinopril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00065	Ubiquinone Biosynthesis	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00163	Olmesartan Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00629	Adefovir Dipivoxil Metabolism Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00154	Ramipril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00497	Tyrosine hydroxylase deficiency	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00479	Plasmalogen Synthesis	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00148	Enalapril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00162	Losartan Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00155	Rescinnamine Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00161	Irbesartan Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00639	Clomipramine Metabolism Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00146	Captopril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00160	Forasartan Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00129	Malate-Aspartate Shuttle	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00587	Angiotensin Metabolism	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00159	Eprosartan Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00147	Cilazapril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00630	Tenofovir Metabolism Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00156	Spirapril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00151	Moexipril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00158	Candesartan Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00157	Trandolapril Action Pathway	1.00000000000102	1.01647431248984e-12	4	0	0	71	978
SMP00055	Alanine Metabolism	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00070	Riboflavin Metabolism	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00468	Degradation of Superoxides	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00352	Primary Hyperoxaluria Type I	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00516	Adrenoleukodystrophy- X-linked	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00454	Repaglinide Action Pathway	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00350	Pyruvate Carboxylase Deficiency	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00641	Doxepin Metabolism Pathway	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00453	Nateglinide Action Pathway	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00052	Beta Oxidation of Very Long Chain Fatty Acids	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00460	Glibenclamide Action Pathway	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00313	Lactic Acidemia	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00018	Alpha Linolenic Acid and Linoleic Acid Metabolism	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00643	Pancreas Function	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00503	Hypophosphatasia	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00017	Vitamin B6 Metabolism	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00517	Carnitine-acylcarnitine translocase deficiency	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00569	Succinyl CoA: 3-ketoacid CoA transferase deficiency	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00071	Ketone Body Metabolism	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00310	Corticotropin Activation of Cortisol Production	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00461	Gliclazide Action Pathway	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00465	Carnitine Synthesis	1.00000000000154	1.53961992729159e-12	5	0	0	71	978
SMP00054	Fatty Acid Elongation In Mitochondria	1.00000000000214	2.13948616091473e-12	7	0	0	71	978
SMP00634	Carbamazepine Metabolism Pathway	1.00000000000214	2.13948616091473e-12	7	0	0	71	978
SMP00322	Vasopressin Regulation of Water Homeostasis	1.00000000000214	2.13948616091473e-12	7	0	0	71	978
SMP00627	Citalopram Metabolism Pathway	1.00000000000214	2.13948616091473e-12	7	0	0	71	978
SMP00544	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	1.00000000000214	2.13948616091473e-12	7	0	0	71	978
SMP00637	Tramadol Metabolism Pathway	1.00000000000214	2.13948616091473e-12	7	0	0	71	978
SMP00646	Fluoxetine Metabolism Pathway	1.00000000000231	2.3137015085571e-12	6	0	0	71	978
SMP00445	Spermidine and Spermine Biosynthesis	1.00000000000231	2.3137015085571e-12	6	0	0	71	978
SMP00478	Nucleotide Excision Repair 	1.00000000000231	2.3137015085571e-12	6	0	0	71	978
SMP00343	Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	1.00000000000231	2.3137015085571e-12	6	0	0	71	978
SMP00628	Nicotine Metabolism Pathway	1.00000000000231	2.3137015085571e-12	6	0	0	71	978
SMP00308	Dopamine Activation of Neurological Reward System	1.00000000000231	2.3137015085571e-12	6	0	0	71	978
SMP00625	Imipramine Metabolism Pathway	1.00000000000231	2.3137015085571e-12	6	0	0	71	978
SMP00027	Pantothenate and CoA Biosynthesis	1.00000000000231	2.3137015085571e-12	6	0	0	71	978
SMP00605	Ifosfamide Metabolism Pathway	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00481	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00127	Glucose-Alanine Cycle	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00073	Butyrate Metabolism	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00480	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00448	Ifosfamide Action Pathway	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00568	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00354	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00123	Betaine Metabolism	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00644	Celecoxib Metabolism Pathway	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00642	Nevirapine Metabolism Pathway	1.00000000000249	2.4862277756582e-12	8	0	0	71	978
SMP00228	Pantoprazole Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00580	GLUT-1 deficiency syndrome	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00232	Cimetidine Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00444	Lactose Synthesis	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00335	Intracellular Signalling Through Histamine H2 Receptor and Histamine	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00225	Esomeprazole Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00604	Cyclophosphamide Metabolism Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00230	Ranitidine Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00734	Roxatidine acetate Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00333	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00226	Omeprazole Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00735	Metiamide Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00452	Threonine and 2-Oxobutanoate Degradation	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00736	Betazole Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00589	Gastric Acid Production	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00229	Rabeprazole Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00233	Nizatidine Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00312	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00466	Transfer of Acetyl Groups into Mitochondria	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00309	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00311	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00227	Lansoprazole Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00231	Famotidine Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00246	Pirenzepine Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00579	Congenital disorder of glycosylation CDG-IId	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00447	Cyclophosphamide Action Pathway	1.00000000000311	3.10931707456531e-12	9	0	0	71	978
SMP00482	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	1.00000000000389	3.88705980344905e-12	10	0	0	71	978
SMP00606	Tamoxifen Metabolism Pathway	1.00000000000389	3.88705980344905e-12	10	0	0	71	978
SMP00471	Tamoxifen Action Pathway	1.00000000000389	3.88705980344905e-12	10	0	0	71	978
SMP00338	Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	1.00000000000389	3.88705980344905e-12	10	0	0	71	978
SMP00566	17-alpha-hydroxylase deficiency (CYP17)	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00371	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00575	11-beta-hydroxylase deficiency (CYP11B1)	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00187	Glycerol Kinase Deficiency	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00635	Valproic Acid Metabolism Pathway	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00717	Apparent mineralocorticoid excess syndrome	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00372	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00576	21-hydroxylase deficiency (CYP21)	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00577	Corticosterone methyl oxidase I deficiency (CMO I)	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00578	Corticosterone methyl oxidase II deficiency - CMO II	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00530	Familial lipoprotein lipase deficiency	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00529	D-glyceric acidura	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00718	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00039	Glycerolipid Metabolism	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00373	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00130	Steroidogenesis	1.00000000000467	4.66727708896739e-12	11	0	0	71	978
SMP00185	Glutaric Aciduria Type I	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00540	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00545	Trifunctional protein deficiency	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00542	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00198	Malonic Aciduria	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00201	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00235	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00181	Ethylmalonic Encephalopathy	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00538	Carnitine palmitoyl transferase deficiency (I)	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00541	Carnitine palmitoyl transferase deficiency (II)	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00502	Malonyl-coa decarboxylase deficiency	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00051	Fatty acid Metabolism	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00016	Propanoate Metabolism	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00539	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	1.00000000000697	6.96818542590051e-12	14	0	0	71	978
SMP00002	Carbamoyl Phosphate Synthetase Deficiency	1.00000000000717	7.16639280643087e-12	13	0	0	71	978
SMP00003	Argininosuccinic Aciduria	1.00000000000717	7.16639280643087e-12	13	0	0	71	978
SMP00205	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	1.00000000000717	7.16639280643087e-12	13	0	0	71	978
SMP00357	Argininemia	1.00000000000717	7.16639280643087e-12	13	0	0	71	978
SMP00001	Citrullinemia Type I	1.00000000000717	7.16639280643087e-12	13	0	0	71	978
SMP00059	Urea Cycle	1.00000000000717	7.16639280643087e-12	13	0	0	71	978
SMP00345	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	1.00000000000801	8.01394933608932e-12	15	0	0	71	978
SMP00344	Acute Intermittent Porphyria	1.00000000000801	8.01394933608932e-12	15	0	0	71	978
SMP00040	Glycolysis	1.00000000000801	8.01394933608932e-12	15	0	0	71	978
SMP00024	Porphyrin Metabolism	1.00000000000801	8.01394933608932e-12	15	0	0	71	978
SMP00531	Glycogenosis- Type VII. Tarui disease	1.00000000000801	8.01394933608932e-12	15	0	0	71	978
SMP00342	Hereditary Coproporphyria (HCP)	1.00000000000801	8.01394933608932e-12	15	0	0	71	978
SMP00346	Porphyria Variegata (PV)	1.00000000000801	8.01394933608932e-12	15	0	0	71	978
SMP00572	Fanconi-bickel syndrome	1.00000000000801	8.01394933608932e-12	15	0	0	71	978
SMP00725	Fructose intolerance- hereditary	1.00000000001083	1.0828491857668e-11	18	0	0	71	978
SMP00561	Fructosuria	1.00000000001083	1.0828491857668e-11	18	0	0	71	978
SMP00064	Fructose and Mannose Degradation	1.00000000001083	1.0828491857668e-11	18	0	0	71	978
SMP00355	Mitochondrial Electron Transport Chain	1.000000000011	1.1002474224994e-11	19	0	0	71	978
SMP00092	Rosuvastatin Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00508	Cholesteryl ester storage disease	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00510	Mevalonic aciduria	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00387	CHILD Syndrome	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00095	Alendronate Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00107	Zoledronate Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00548	Mitochondrial complex II deficiency	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00389	Smith-Lemli-Opitz Syndrome (SLOS)	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00112	Risedronate Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00119	Fluvastatin Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00079	Ibandronate Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00057	Citric Acid Cycle	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00209	Hypercholesterolemia	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00388	Chondrodysplasia Punctata II- X Linked Dominant (CDPX2)	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00386	Desmosterolosis	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00551	Pyruvate dehydrogenase deficiency (E2)	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00511	Wolman disease	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00023	Steroid Biosynthesis	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00099	Lovastatin Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00509	Hyper-IgD syndrome	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00131	Atorvastatin Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00082	Simvastatin Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00117	Pamidronate Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00546	Congenital lactic acidosis	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00319	Lysosomal Acid Lipase Deficiency (Wolman Disease)	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00111	Cerivastatin Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00549	2-ketoglutarate dehydrogenase complex deficiency	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00547	Fumarase deficiency	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00089	Pravastatin Action Pathway	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00550	Pyruvate dehydrogenase deficiency (E3)	1.00000000001309	1.30893745266151e-11	21	0	0	71	978
SMP00025	Phospholipid Biosynthesis	1.00000000001685	1.68495842369501e-11	26	0	0	71	978
